Chromovitrectomy is an advanced surgical technique that enhances the safety and efficacy of pars plana vitrectomy (PPV) through the intraoperative use of vital dyes. These dyes selectively stain intraocular tissues, such as the internal limiting membrane (ILM), epiretinal membranes (ERM), and posterior hyaloid, allowing for improved visualization and targeted membrane peeling. This technique is particularly valuable in complex vitreoretinal surgeries, including macular hole repair, epiretinal membrane removal, and diabetic tractional retinal detachment. Commonly used dyes include indocyanine green (ICG), trypan blue, and brilliant blue G, each with distinct staining affinities and safety profiles. Brilliant blue G, for example, preferentially stains the ILM with minimal retinal toxicity, making it a preferred choice in macular surgeries. The judicious selection of dyes and application techniques is critical to optimize surgical outcomes while minimizing potential adverse effects, such as retinal toxicity or elevated intraocular pressure. Chromovitrectomy has significantly contributed to the evolution of vitreoretinal surgery by improving membrane contrast, reducing surgical time, and decreasing iatrogenic retinal trauma. Emerging developments in dye formulations and delivery systems aim to further refine this technique, ensuring better safety margins and enhanced surgical precision. Chromovitrectomy represents a pivotal advancement in vitreoretinal surgery, enabling more precise tissue manipulation and improved anatomical and functional outcomes. Ongoing research continues to optimize dye characteristics and explore novel agents, reinforcing the essential role of chromovitrectomy in modern retinal practice.